NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

Published 07/06/2024, 10:17
Updated 07/06/2024, 11:40
© Reuters.  Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
BRZE
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Braze, Inc. (NASDAQ:BRZE) rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.

Braze reported first-quarter revenue of $135.459 million, beating estimates of $131.668 million. The company reported a first-quarter adjusted loss of 5 cents per share, beating estimates for a loss of 10 cents per share, according to Benzinga Pro.

Braze shares jumped 14.3% to $42.02 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Venus Concept Inc. (NASDAQ:VERO) rose 135.8% to $1.46 in today's pre-market trading after gaining 16% on Thursday. Venus Concept was notified it regained compliance with Nasdaq’s minimum equity requirement.
  • Versus Systems Inc. (NASDAQ:VS) gained 89.1% to $3.11 in pre-market trading after jumping 27% on Thursday.
  • GameStop Corp. (NYSE:GME) shares gained 35.3% to $63.00 in pre-market trading after jumping around 47% on Thursday.
  • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 25.9% to $0.6850 in pre-market trading.
  • ESGL Holdings Limited (NASDAQ:ESGL) shares rose 22.7% to $1.19 in pre-market trading.
  • Trinity Place Holdings Inc. (NYSE:TPHS) shares rose 20.3% to $0.1460 in pre-market trading after declining around 11% on Thursday.
  • Presto Automation Inc. (NASDAQ:PRST) rose 19.2% to $0.0905 in pre-market trading after declining 27% on Thursday.
  • Geron Corporation (NASDAQ:GERN) shares climbed 14.3% to $4.45 in pre-market trading as the company reported the FDA approval of RYTELO™ (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
  • AMC Entertainment Holdings, Inc. (NYSE:AMC) shares gained 12.7% to $6.53 in pre-market trading after gaining over 12% on Thursday.
Losers
  • Biomea Fusion, Inc. (NASDAQ:BMEA) shares declined 59.2% to $4.60 in pre-market trading after the company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold.
  • Xylo Technologies Ltd. (NASDAQ:XYLO) shares declined 19.8% to $1.50 in pre-market trading after surging over 6% on Thursday.
  • Sacks Parente Golf, Inc. (NASDAQ:SPGC) shares fell 19.8% to $0.43 in pre-market trading.
  • Virax Biolabs Group Limited (NASDAQ:VRAX) shares dipped 19.3% to $1.59 in pre-market trading after jumping over 85% on Thursday.
  • Splash Beverage Group, Inc. (NASDAQ:SBEV) shares fell 17.1% to $0.2112 in pre-market trading.
  • Moving iMage Technologies, Inc. (NYSE:MITQ) fell 15% to $0.57 in pre-market trading after declining 33% on Thursday. Moving iMage Technologies was recently awarded a multi-million dollar contract.
  • Bright Green Corporation (NASDAQ:BGXX) shares fell 14.7% to $0.2990 in pre-market trading after declining around 8% on Thursday.
  • Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) shares fell 13% to $6.55 in pre-market trading after posting weaker-than-expected second-quarter results.
  • DocuSign, Inc. (NASDAQ:DOCU) shares fell 7.1% to $50.70 in pre-market trading. DocuSign reported better-than-expected earnings for its first quarter and the company’s board also authorized a $1 billion increase to its existing stock repurchase program. The company said it sees second-quarter billings in the range of $715 million to $725 million.
  • Vail Resorts, Inc. (NYSE:MTN) shares declined 6.8% to $180.77 in pre-market trading after the company reported weaker-than-expected results for its third quarter on Thursday.
Now Read This: Vail Resorts, DocuSign And 3 Stocks To Watch Heading Into Friday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.